Skip to main content

Table 4 Prevalence of inappropriate drug prescription (Dependent on disease or condition)

From: Prevalence of inappropriate medication using Beers criteria in Japanese long-term care facilities

Disease or condition Drug Severity n/N * %
Heart failure Disopyramide, high sodium content drugs High 4/114 3.5
Seizures or epilepsy Chlorpromazine, thioridazine High 2/57 3.5
Blood clotting disorders or receiving anticoagulant therapy Aspirin, NSAIDs, dipyridamole, ticlopidine High 4/27 14.8
Stress incontinence** α-Blockers, anticholinergics, tricyclic antidepressants, long-acting benzodiazepines High 89/1028 8.7
Arrhythmias Tricyclic antidepressants High 1/106 0.9
Insomnia Decongestants, theophylline, methylphenidate, MAOI, amphetamines High 4/92 4.3
Parkinson's disease Metoclopramide, conventional antipsychotics High 19/88 11.4
Cognitive impairment Barbiturates, anticholinergics, antispasmodics, muscle relaxants, CNS stimulants High 52/1273 4.1
Depression Sympatholytic agents High 8/119 6.7
Syncope or falls Short to intermediate-acting benzodiazepine, tricyclic antidepressants High 23/103 22.3
COPD Long-acting benzodiazepines, β-blockers High 1/44 2.3
Chronic constipation Calcium channel blockers, anticholinergics, tricyclic antidepressants Low 165/548 30.1
Use of any of above for each disease or condition 300/1669 18.0
  1. * N: Number of patients with the disease or condition. n: Number of patients treated with any of drug(s) that are inappropriate for that disease or condition.
  2. ** We could not identify the patients with 'stress incontinence' because the MDS data were limited to 'incontinence' in general.